VANESSA SBORDONI: Open Payments
NPI 1891576575 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $553
Food & beverage: $454Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $163 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Genmab U.S., Inc. | 1 | $120 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| Adaptive Biotechnologies Corporation | 1 | $50 |
Products named: TECVAYLI, LYNPARZA, Epkinly, FOTIVDA, clonoSEQ, ERLEADA.
Industry payments across AZ — which companies pay providers there.
